Other Clinical Trial - Post Approval Study - Evaluate the Long-Term Safety

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

A prospective, multicenter, single arm, interventional study. The target patient population for this study are adult subjects with WNBAs of the anterior and posterior intracranial circulation. The primary effectiveness outcome of the study is adequate intracranial aneurysm occlusion on the 1 year angiogram as adjudicated by a core laboratory.

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT03207087` - The WEB®-IT China Clinical Study	N/A
	Active, not recruiting	`NCT02191618` - The WEB-IT Clinical Study	N/A

NCT number	NCT04839705
Study type	Interventional
Source	Microvention-Terumo, Inc.
Contact
Status	Recruiting
Phase	N/A
Start date	August 24, 2022
Completion date	December 2029

Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device — WEB PAS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms